Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 330 participants.
Also called NCT05203224
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 330 participants
- Sponsor
- Registry
-
NCT05203224
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia
- Registry status
- Completed
Technical summary
Registry record NCT05203224. Allocation not applicable; no masking; primary purpose treatment. Start 2022-02-18 (actual); primary completion 2025-11-24 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Dornase Alfa
- Lead sponsor
- University of Melbourne
Record details
- Record id
cardio:ct-nct05203224- Content hash
c11133c70b2a0b1ad9ab5cf40403e013149193477bb286e3d7353d860b18ec03